FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Colistimethate Sodium Injection
Status: Discontinuation
»Therapeutic Categories:

Perrigo Pharmaceuticals (New 02/07/2017)

Company Contact Information:
800-775-2054

Presentation Posting Date Related Information
150 mg (NDC 00574-0858-01) N/A Perrigo Pharmaceuticals is discontinuing the product Colistimethate Injection, USP 150 Mg NDC 00574-0858-01, effective immediately. Existing inventory has been depleted.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English